Dr. Moises Roizental: All About Weight Management and Obesity Medication: GLP 1 Agonists

Know Your Physio

Send us a Text Message.

The ever-increasing issue of obesity and its related health complications brings with it the need for effective treatment. We are joined today by a board-certified vascular and interventional radiologist, Dr. Moises Roizental, to talk all things weight loss and obesity medication (specifically GLP-1 agonists). Dr. Roi explains the challenge of overcoming obesity and the role GLP-1 agonists play in alleviating the struggle. We learn about the multitude of benefits, obesity-related and otherwise, as well as the indications, contraindications, and side effects. Tune in to hear about the long-term benefits of investing in your health and how to get the best results from this life-changing medication!

Key Points From This Episode:

• What “bioavailability” means. [00:22]
• Introducing vascular and interventional radiologist, Dr. Moises Roizental. [03:13]
• Introducing today’s topic: weight loss and obesity medication. [03:39]
• Where to find the Spanish version of this episode. [04:23]
• What GLP-1 agonists are, how they work, and their metabolic benefits. [05:59]
• The weight loss results of GLP-1 agonists. [11:22]
• What to pair the meds with to see results. [11:38]
• Other non-obesity-related benefits of the medication. [12:09]
• The history of the medication. [14:21]
• Under which circumstances GLP-1 agonists are contraindicated. [15:15]
• How GLP-1 agonists alleviate the challenge of overcoming obesity. [16:47]
• Dr. Roi’s personal experimentation with the medication. [18:53]
• The availability and accessibility of the meds. [20:39]
• Some of the long-term benefits of investing in your health. [21:51]
• The side effects of GLP-1 agonists. [23:49]
• Controversial use/abuse of the medication. [24:54]
• The recommended dosage of GLP-1 agonists. [27:29]
• Dr. Roi’s advice for those interested in exploring this medication. [30:11]
• Safe sources of GLP-1 agonists. [34:04]
• Dr. Roi’s for the future of GLP-1 agonists. [35:45]
• Why Dr. Roi has shifted from intervention towards disease prevention. [37:06]

Links Mentioned in Today’s Episode:

Dr. Moises Roizental on LinkedIn

Dr. Moises Roizental on Twitter

Dr. Moises Roizental on Instagram

Email Dr. Moises Roizental

Hambre y Hormonas

Hambre y Hormonas on Instagram

Wegovy

Ozempic

Saxenda

Mounjaro

Click HERE to save on BiOptimizers Magnesium

Andrés Preschel

Know Your Physio Podcast

Support the Show.